JAMA BOGART: Open Payments
NPI 1801972682 · NEVADA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 33 payments from 12 companies in 2025. Trend: 2023 $534 · 2024 $326 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $175 |
| Vanda Pharmaceuticals Inc. | 7 | $164 |
| Axsome Therapeutics, Inc. | 5 | $76 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
| ABBVIE INC. | 2 | $29 |
| Astellas Pharma US Inc | 1 | $22 |
| SANOFI PASTEUR INC. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
Products named: REXULTI, FANAPT, Auvelity, SPRAVATO, UZEDY, HETLIOZ, ABILIFY MAINTENA, Veozah.
Industry payments across MO — which companies pay providers there.
